Abbott Laboratories
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Asset Breakdown FY2009
Total Assets: $52.58B
Liabilities Breakdown FY2009
Total Liabilities: $29.44B
Asset Breakdown
Total Assets: $52.58B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $8.81B | 16.8% |
| Accounts Receivable | $6.54B | 12.4% |
| Inventory | $3.26B | 6.2% |
| Property, Plant & Equipment | $7.62B | 14.5% |
| Goodwill | $13.20B | 25.1% |
| Intangible Assets | $6.29B | 12.0% |
| Other Assets | $6.85B | 13.0% |
Liabilities Breakdown
Total Liabilities: $29.44B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.28B | 4.4% |
| Long-Term Debt | $11.27B | 38.3% |
| Other Liabilities | $16.89B | 57.4% |